In partnership with BEACON (Best Evidence Advancing Child health in Ohio Now!), the State of Ohio is working with various healthcare leaders, stakeholders, and medical professionals to evaluate and improve prescribing of atypical antipsychotics and other psychotropic medications to the youngest members of the Medicaid population. Over the next three years, the state will invest $1 million to launch this new quality improvement initiative.